KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Assets Average: 2009-2025

Historic Assets Average for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $40.0 billion.

  • Teva Pharmaceutical Industries' Assets Average fell 3.74% to $40.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 billion, marking a year-over-year decrease of 3.74%. This contributed to the annual value of $41.4 billion for FY2024, which is 5.35% down from last year.
  • According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Assets Average is $40.0 billion, which was up 1.83% from $39.3 billion recorded in Q2 2025.
  • Teva Pharmaceutical Industries' 5-year Assets Average high stood at $49.8 billion for Q1 2021, and its period low was $38.9 billion during Q1 2025.
  • Its 3-year average for Assets Average is $41.6 billion, with a median of $42.1 billion in 2024.
  • Data for Teva Pharmaceutical Industries' Assets Average shows a maximum YoY dropped of 11.66% (in 2021) over the last 5 years.
  • Over the past 5 years, Teva Pharmaceutical Industries' Assets Average (Quarterly) stood at $47.8 billion in 2021, then declined by 7.59% to $44.1 billion in 2022, then decreased by 3.05% to $42.8 billion in 2023, then declined by 5.25% to $40.5 billion in 2024, then dropped by 3.74% to $40.0 billion in 2025.
  • Its last three reported values are $40.0 billion in Q3 2025, $39.3 billion for Q2 2025, and $38.9 billion during Q1 2025.